Assessment of asthma control in adults

Clinical Asthma: Theory and Practice

Volumn , Issue , 2014, Pages 163-173

  Farah, Claude S ^a,b,c   Reddel, Helen K ^a,b,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ANZAC Research Institute   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84925078565     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b16468     Document Type: Chapter

References (50)

1. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA) report: Global strategy for asthma management and prevention. 2011 [cited 2012 July]. Available from: http://www.ginasthma.org.
2. Reddel HK, Taylor DR, Bateman ED, et al. An Official American Thoracic Society/European Respiratory Society Statement: Asthma control and exacerbations-standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59-99.
3. Taylor DR, Bateman ED, Boulet LP, et al. A new perspec-tive on concepts of asthma severity and control. Eur Respir J. 2008;32:545-554.
4. Meltzer EO, Busse WW, Wenzel SE, et al. Use of the Asthma Control Questionnaire to predict future risk of asthma exacer-bation. J Allergy Clin Immunol. 2011;127:167-172.
5. Busse WW, Lemanske Jr RF, Gern JE. Role of viral respira-tory infections in asthma and asthma exacerbations. Lancet. 2010;376:826-834.
6. Australian Centre for Asthma Monitoring. Asthma in Australia 2011. Canberra: Australian Institute of Health and Welfare, 2011.
7. O’Byrne PM, Reddel HK, Eriksson G, et al. Measuring asthma control: A comparison of three classification systems. Eur Respir J. 2010;36:269-276.
8. British Thoracic Society and Scottish Intercollegiate Guidelines Network. Managing Asthma in Adults. 2011 [cited 2012 July]. Available from: http://www.brit-thoracic.org.uk/Guidelines/Asthma-Guidelines.aspx.
9. Salome CM, Reddel HK, Ware SI, et al. Effect of budesonide on the perception of induced airway narrowing in subjects with asthma. Am J Respir Crit Care Med. 2002;165:15-21.
10. Calhoun WJ, Sutton LB, Emmett A, et al. Asthma variabil-ity in patients previously treated with beta2-agonists alone. J Allergy Clin Immunol. 2003;112:1088-1094.
11. Taylor DR. The beta-agonist saga and its clinical rel-evance: On and on it goes. Am J Respir Crit Care Med. 2009;179:976-978.
12. McNicholl DM, Megarry J, McGarvey LP, et al. The utility of cardiopulmonary exercise testing in difficult asthma. Chest. 2011;139:1117-1123.
13. Juniper EF, O’Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14:902-907.
14. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: A survey for assessing asthma control. J Allergy Clin Immunol. 2004;113:59-65.
15. Juniper EF, O’Byrne PM, Roberts JN. Measuring asthma con-trol in group studies: Do we need airway calibre and rescue beta2-agonist use? Respir Med. 2001;95:319-323.
16. Juniper EF, Bousquet J, Abetz L, et al. Identifying “well-controlled” and “not well-controlled” asthma using the Asthma Control Questionnaire. Respir Med. 2006;100:616-621.
17. Jenkins CR, Thien FC, Wheatley JR, et al. Traditional and patient-centred outcomes with three classes of asthma medi-cation. Eur Respir J. 2005;26:36-44.
18. Schatz M, Kosinski M, Yarlas AS, et al. The minimally impor-tant difference of the Asthma Control Test. J Allergy Clin Immunol. 2009;124:719-723. e1.
19. Pinnock H, Burton C, Campbell S et al. Clinical implications of the Royal College of Physicians three questions in routine asthma care: a real-life validation study. Prim Care Respir J. 2012;21:288-294.
20. Rabe KF, Adachi M, Lai CKW, et al. Worldwide sever-ity and control of asthma in children and adults: The global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114:40-47.
21. Reddel H, Ware S, Marks G, et al. Differences between asthma exacerbations and poor asthma control. Lancet. 1999;353:364-369.
22. Levy ML, Quanjer PH, Booker R, et al. Diagnostic spirom-etry in primary care: Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations: A General Practice Airways Group (GPIAG)1 document, in association with the Association for Respiratory Technology & Physiology (ARTP)2 and Education for Health3. www.gpiag.org, www.artp.org, and www.educationforhealth.org.uk. Prim Care Respir J. 2009;18:130-147.
23. Cooper BG. An update on contraindications for lung function testing. Thorax. 2011;66:714-723.
24. Reddel HK, Jenkins CR, Marks GB, et al. Optimal asthma control, starting with high doses of inhaled budesonide. Eur Respir J. 2000;16:226-235.
25. Shingo S, Zhang J, Reiss TF. Correlation of airway obstruc-tion and patient-reported endpoints in clinical studies. Eur Respir J. 2001;17:220-224.
26. Kitch BT, Paltiel AD, Kuntz KM, et al. A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up. Chest. 2004;126:1875-1882.
27. Magnan A, Meunier JP, Saugnac C, et al. Frequency and impact of allergic rhinitis in asthma patients in everyday gen-eral medical practice: A French observational cross-sectional study. Allergy. 2008;63:292-298.
28. Talreja N, Baptist AP. Effect of age on asthma control: Results from the National Asthma Survey. Ann Allergy Asthma Immunol. 2011;106:24-29.
29. Ford ES, Mannino DM. Time trends in obesity among adults with asthma in the United States: Findings from three national surveys. J Asthma. 2005;42:91-95.
30. Farah CS, Kermode JA, Downie SR, et al. Obesity is a deter-minant of asthma control, independent of inflammation and lung mechanics. Chest. 2011;140:659-666.
31. Nicolacakis K, Skowronski ME, Coreno AJ, et al. Observations on the physiological interactions between obesity and asthma. J Appl Physiol. 2008;105:1533-1541.
32. Mahadev S, Farah CS, King GG, et al. Obesity, expiratory flow limitation and asthma symptoms. Pulm Pharmacol Ther. 2013;26(4):438-443.
33. Teodorescu M, Polomis DA, Hall SV, et al. Association of obstructive sleep apnea risk with asthma Control in Adults. Chest. 2010;138:543-550.
34. Kiljander TO, Harding SM, Field SK, et al. Effects of esomeprazole 40 mg twice daily on asthma: A random-ized placebo-controlled trial. Am J Respir Crit Care Med. 2006;173:1091-1097.
35. Parsons JP, Benninger C, Hawley MP, et al. Vocal cord dysfunction: Beyond severe asthma. Respir Med. 2010;104:504-509.
36. Morris MJ, Christopher KL. Diagnostic criteria for the classification of vocal cord dysfunction. Chest. 2010;138:1213-1223.
37. Althuis MD, Sexton M, Prybylski D. Cigarette smoking and asthma symptom severity among adult asthmatics. J Asthma. 1999;36:257-264.
38. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1:1645-1648.
39. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339:1194-1200.
40. Chalmers GW, Macleod KJ, Little SA, et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax. 2002;57:226-230.
41. Xuan W, Peat JK, Toelle BG, et al. Lung function growth and its relation to airway hyperresponsiveness and recent wheeze. Results from a longitudinal population study. Am J Respir Crit Care Med. 2000;161:1820-1824.
42. Taylor DR, Palmay R, Cowan JO, et al. Long term perfor-mance characteristics of an electrochemical nitric oxide anal-yser. Respir Med. 2011;105:211-217.
43. Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med. 2001;164:738-743.
44. Michils A, Baldassarre S, Van Muylem A. Exhaled nitric oxide and asthma control: A longitudinal study in unselected patients. Eur Respir J. 2008;31:539-546.
45. Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: Interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602-615.
46. Pavord ID, Pizzichini MM, Pizzichini E, et al. The use of induced sputum to investigate airway inflammation. Thorax. 1997;52:498-501.
47. Farah CS, King GG, Brown NJ, et al. The role of the small air-ways in the clinical expression of asthma in adults. J Allergy Clin Immunol. 2012;129:381-387.
48. Farah CS, King GG, Brown NJ, et al. Ventilation hetero-geneity predicts asthma control in adults following inhaled corticosteroid dose titration. J Allergy Clin Immunol. 2012;130:61-68.
49. Sorkness RL, Bleecker ER, Busse WW, et al. Lung function in adults with stable but severe asthma: Air trapping and incom-plete reversal of obstruction with bronchodilation. J Appl Physiol. 2008;104:394-403.
50. In’t Veen JCCM, Beekman AJ, Bel EH, et al. Recurrent exac-erbations in severe asthma are associated with enhanced air-way closure during stable episodes. Am J Respir Crit Care Med. 2000;161:1902-1906.